Adaptyv Bio's banner

Adaptyv Bio

@adaptyvbio • 5,667 subscribers

The automated lab for agentic biology

Shorts

We’re partnering with Paul Jankura to launch the biggest Protein Design Competition in the world, challenging people around the world to use AI to design new potential drug candidates for diseases that affect millions of lives. The competition will feature five challenges, each focused on a specific disease or biological mechanism. Compared to previous competitions, it will be a big step-up in complexity and scale to push the boundaries of AI-driven protein design. Together with Anthropic, we’re sponsoring over $1 million in experimental validation, making it possible to test more than 5,000 protein designs in our automated lab at no cost to participants. Anthropic is providing an additional $1 million in Claude credits. All experimental results will be published openly on Proteinbase, including designs that didn’t work, so anyone can access the data and build on what we learn. The competition is open to everyone and free to enter. It will feature 3 tracks: - Track 1 is aimed at expert protein designers, with up to 20 teams to be selected. - Track 2 is targeting life science academics and industry researchers. - Track 3 is open to everyone from tech enthusiasts to high-school students. By combining Anthropic’s models with access to our automated lab, we want to make it possible for anyone with a laptop and an internet connection to join the global effort to advance human health with AI. A big thanks to Modal for contributing compute for protein design and to Twist Bioscience for contributing the DNA for the experimental validation! Sign up link below -

We’re partnering with Paul Jankura to launch the biggest Protein Design Competition in the world, challenging people around the world to use AI to design new potential drug candidates for diseases that affect millions of lives. The competition will feature five challenges, each focused on a specific disease or biological mechanism. Compared to previous competitions, it will be a big step-up in complexity and scale to push the boundaries of AI-driven protein design. Together with Anthropic, we’re sponsoring over $1 million in experimental validation, making it possible to test more than 5,000 protein designs in our automated lab at no cost to participants. Anthropic is providing an additional $1 million in Claude credits. All experimental results will be published openly on Proteinbase, including designs that didn’t work, so anyone can access the data and build on what we learn. The competition is open to everyone and free to enter. It will feature 3 tracks: - Track 1 is aimed at expert protein designers, with up to 20 teams to be selected. - Track 2 is targeting life science academics and industry researchers. - Track 3 is open to everyone from tech enthusiasts to high-school students. By combining Anthropic’s models with access to our automated lab, we want to make it possible for anyone with a laptop and an internet connection to join the global effort to advance human health with AI. A big thanks to Modal for contributing compute for protein design and to Twist Bioscience for contributing the DNA for the experimental validation! Sign up link below -

209,288 просмотров

We're launching Challenge 1 of the Anthropic x Adaptyv Protein Design Competition on Proteinbase: design a conditional binder to EGFR, a key cancer target. The goal: bind EGFR under the acidic conditions of the tumor environment, but not at the normal pH around healthy cells. Moreover, the proteins must bind to both the human and the mouse variant of EGFR to support easier preclinical testing

We're launching Challenge 1 of the Anthropic x Adaptyv Protein Design Competition on Proteinbase: design a conditional binder to EGFR, a key cancer target. The goal: bind EGFR under the acidic conditions of the tumor environment, but not at the normal pH around healthy cells. Moreover, the proteins must bind to both the human and the mouse variant of EGFR to support easier preclinical testing

61,300 просмотров

Announcing Challenge 2 of the Anthropic x Adaptyv Protein Design Competition! Humira, the best-selling drug ever, blocks TNF-α, an inflammation marker protein that’s overexpressed in rheumatoid arthritis and Crohn’s disease. In this challenge, the goal is to make a better binder for TNF-α that also releases selectively at pH 6.0 in the endosome of cells to improve drug half-life. The protein must also bind both human and mouse TNF-α, making it easier to test the same design in preclinical models.

Announcing Challenge 2 of the Anthropic x Adaptyv Protein Design Competition! Humira, the best-selling drug ever, blocks TNF-α, an inflammation marker protein that’s overexpressed in rheumatoid arthritis and Crohn’s disease. In this challenge, the goal is to make a better binder for TNF-α that also releases selectively at pH 6.0 in the endosome of cells to improve drug half-life. The protein must also bind both human and mouse TNF-α, making it easier to test the same design in preclinical models.

31,185 просмотров

Today we're dropping the "beta" tag from Adaptyv, launching our new website and announcing our $8M seed round. When we started Adaptyv a few years ago, our core belief was: AI models for biology are only as good as the experimental data they're trained on and the hypotheses they can test in the real world. Now, after a year of working with many great partners, we’ve scaled our infrastructure to the point that we're now open to anyone who wants to use our platform! Overall, this year, over 30 companies started using Adaptyv to validate their protein designs - from some of the biggest pharmas to frontier AI labs to many, many techbio startups. We've run hundreds of experiments, tested well over 10,000 proteins this year and are generating the data that validates the best AI models currently in development.

Today we're dropping the "beta" tag from Adaptyv, launching our new website and announcing our $8M seed round. When we started Adaptyv a few years ago, our core belief was: AI models for biology are only as good as the experimental data they're trained on and the hypotheses they can test in the real world. Now, after a year of working with many great partners, we’ve scaled our infrastructure to the point that we're now open to anyone who wants to use our platform! Overall, this year, over 30 companies started using Adaptyv to validate their protein designs - from some of the biggest pharmas to frontier AI labs to many, many techbio startups. We've run hundreds of experiments, tested well over 10,000 proteins this year and are generating the data that validates the best AI models currently in development.

11,636 просмотров

Videos

Anya Rossi

sweetdream.ai

SweetDream.ai•Sponsored•Livecam

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

Exclusive private shows

1.2k viewers online

Private Show

Join now for exclusive access

Free preview available • Premium content

We raised a $40M Series A to build the automated lab for agentic biology. Last week, we shared the work we did with Paul Jankura: Claude designed proteins, sent them to our automated wet lab, and got real experimental data back. We believe this is where biology is going: AI agents designing experiments, running them in automated wet labs, learning from the results and iterating. But AI can only move as fast as the experiments behind it. To use the potential of AI to cure all diseases, we need to build high-throughput wet lab infrastructure: a “biological gigafactory”. That’s exactly what we’re doing at Adaptyv. Over the past year we’ve grown our lab throughput by over 5x and onboarded more than 100 customers, ranging from bio AI labs like Chai Discovery and Boltz to pharmas like Roche and Novo Nordisk to dozens and dozens of new startups that use AI to radically speed up drug discovery.

We raised a $40M Series A to build the automated lab for agentic biology. Last week, we shared the work we did with Paul Jankura: Claude designed proteins, sent them to our automated wet lab, and got real experimental data back. We believe this is where biology is going: AI agents designing experiments, running them in automated wet labs, learning from the results and iterating. But AI can only move as fast as the experiments behind it. To use the potential of AI to cure all diseases, we need to build high-throughput wet lab infrastructure: a “biological gigafactory”. That’s exactly what we’re doing at Adaptyv. Over the past year we’ve grown our lab throughput by over 5x and onboarded more than 100 customers, ranging from bio AI labs like Chai Discovery and Boltz to pharmas like Roche and Novo Nordisk to dozens and dozens of new startups that use AI to radically speed up drug discovery.

183,724 просмотров • 1 месяц назад

The possibilities for AI-powered protein design are endless! In this case study we show how we used BindCraft to engineer a programmable maltose biosensor from scratch, including wet lab validation at Adaptyv of course. We envision a future where every biologist can make their own bespoke protein tools to investigate environmental samples, cell behaviour or create therapeutics. AI-based protein design can enable that future if powered by rapid wet lab validation. Once the cycle from design → test → application shrinks to weeks, the frontier explodes.

The possibilities for AI-powered protein design are endless! In this case study we show how we used BindCraft to engineer a programmable maltose biosensor from scratch, including wet lab validation at Adaptyv of course. We envision a future where every biologist can make their own bespoke protein tools to investigate environmental samples, cell behaviour or create therapeutics. AI-based protein design can enable that future if powered by rapid wet lab validation. Once the cycle from design → test → application shrinks to weeks, the frontier explodes.

52,226 просмотров • 1 год назад

AI has solved software. Biology is the next frontier. We're hiring across every team at Adaptyv. We’ve built the best automated lab for protein designers to experimentally test their AI-designed proteins. Today, the most advanced protein design companies run their wet-lab work on Adaptyv, from the biggest biopharmas to frontier AI labs to dozens of virtual biotech startups. Demand has grown faster than we have, so we’re hiring across the board: • Bio: Research associates, scientists and lab technicians to develop and run new assays at scale. • Lab automation: Engineers and interns to onboard new lab instruments and scale our automation infrastructure. • Software: Product and backend engineers to scale LabOS, our internal lab orchestration platform, our API for agents and the data pipelines that turn messy physical-world data into clean results. • Partnerships, customer success and operations: Building partnerships with AI & pharma labs, making sure customers understand their data and can run more campaigns, making sure the company operations run smoothly

AI has solved software. Biology is the next frontier. We're hiring across every team at Adaptyv. We’ve built the best automated lab for protein designers to experimentally test their AI-designed proteins. Today, the most advanced protein design companies run their wet-lab work on Adaptyv, from the biggest biopharmas to frontier AI labs to dozens of virtual biotech startups. Demand has grown faster than we have, so we’re hiring across the board: • Bio: Research associates, scientists and lab technicians to develop and run new assays at scale. • Lab automation: Engineers and interns to onboard new lab instruments and scale our automation infrastructure. • Software: Product and backend engineers to scale LabOS, our internal lab orchestration platform, our API for agents and the data pipelines that turn messy physical-world data into clean results. • Partnerships, customer success and operations: Building partnerships with AI & pharma labs, making sure customers understand their data and can run more campaigns, making sure the company operations run smoothly

15,109 просмотров • 4 месяцев назад

Больше нет контента для загрузки